<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01187225</url>
  </required_header>
  <id_info>
    <org_study_id>0930/09</org_study_id>
    <nct_id>NCT01187225</nct_id>
  </id_info>
  <brief_title>Fibrinogen Concentrate In Children After Cardiac Surgery</brief_title>
  <acronym>FiCCS</acronym>
  <official_title>Fibrinogen Concentrate to Treat Bleeding in Children Undergoing Cardiac Surgery With Pump: a Randomised Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate prospectively whether concentrate fibrinogen reduces
      blood losses, transfusion requirements and occurrence of clinical complications compared to
      cryoprecipitate in children after cardiac surgery with pump.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgery in children may be associated with excessive perioperative bleeding.
      Perioperative excessive bleeding is associated with need of transfusion with allogeneic blood
      products such as red blood cells, fresh frozen plasma, platelet pools, and cryoprecipitate.
      Furthermore, bleeding may result in re-exploration, which is associated with increased
      morbidity and mortality.Recent studies have shown that patients and children undergoing
      cardiac surgery with pump often experience a significant drop in their levels and function of
      fibrinogen, and it would be in part responsible for the bleeding. In most centre world-wide,
      it is common practice to treat bleeding in these patients with cryoprecipitate in order to
      substitute fibrinogen. Fibrinogen concentrate (Haemocomplettan P)may reduce perioperative
      bleeding, requirements of blood transfusion and clinical outcomes in children undergoing
      cardiac surgery with pump, compared to cryoprecipitate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients receiving any allogeneic blood products</measure>
    <time_frame>From ICU admission until hospital discharge</time_frame>
    <description>Percentage of patients exposed to allogeneic blood products (red blood cells, FFP, platelet concentrate and cryoprecipitate) after ICU admission until hospital discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Up to ICU discharge</time_frame>
    <description>Length of ICU stay - days since arrival at ICU until discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical complications - renal failure, respiratory failure,sepsis, myocardial ischemia, stroke</measure>
    <time_frame>Up to hospital discharge</time_frame>
    <description>Clinical complications since intraoperative until hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation free-days</measure>
    <time_frame>Up to ICU discharge</time_frame>
    <description>Number of days without mechanical ventilation during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Up to hospital discharge</time_frame>
    <description>Number of days since arrival at ICU until hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressors free-days</measure>
    <time_frame>Up to ICU discharge</time_frame>
    <description>Number of days without vasopressors during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative transfusion</measure>
    <time_frame>intraoperative period</time_frame>
    <description>intraoperative requirements of any blood product (red blood cells, FFP, platelet concentrate and cryoprecipitate))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative blood losses</measure>
    <time_frame>from ICU admission until hospital discharge</time_frame>
    <description>postoperative blood losses determined by the weight of dressings at intraoperative and chest tube drainage 12h and 24h after ICU admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Cardiac Surgical Procedures</condition>
  <condition>Blood Coagulation Disorders</condition>
  <condition>Fibrinogen</condition>
  <condition>Cryoprecipitate</condition>
  <arm_group>
    <arm_group_label>Fibrinogen concentrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cryoprecipitate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fibrinogen concentrate</intervention_name>
    <description>In this arm, children (&lt; 18 year-old)undergoing cardiac surgery with pump will receive fibrinogen concentrate (60 mg/Kg) if they present clinically significant bleeding associated to low levels of fibrinogen (&lt; 1g/L) or TEG &lt; 7 mm</description>
    <arm_group_label>Fibrinogen concentrate</arm_group_label>
    <other_name>Haemocompletan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cryoprecipitate</intervention_name>
    <description>In this arm, children (&lt; 18 year-old)undergoing cardiac surgery with pump will receive cryoprecipiate (10 ml/Kg) if they present clinically significant bleeding associated to low levels of fibrinogen (&lt; 1g/L) or TEG &lt; 7 mm</description>
    <arm_group_label>Cryoprecipitate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgery with pump

          -  Age until 18 years

          -  Written informed consent

          -  Clinically important bleeding in intraoperative

          -  Fibrinogen lower than 1 g/L or TEG &lt; 7 mm

        Exclusion Criteria:

          -  Previous coagulopathy (clinical history or INR &gt; 1.5)

          -  Low platelet count (lower than 100.000)

          -  Product allergy

          -  Urgent procedures

          -  Active infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Incor - Heart Institute - University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2010</study_first_submitted>
  <study_first_submitted_qc>August 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2010</study_first_posted>
  <last_update_submitted>January 2, 2013</last_update_submitted>
  <last_update_submitted_qc>January 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ludhmila Abrah√£o Hajjar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cardiac surgical procedures</keyword>
  <keyword>Fibrinogen</keyword>
  <keyword>Bleeding</keyword>
  <keyword>Cryoprecipitate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

